Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits: Presented at the Seventy-fourth Annual Meeting of the Society for Vascular Surgery, San Diego, CA, August 18-21, 2021.

Nicholas Govsyeyev,Marc P Bonaca,Jayer Chung,Gabriele Piffaretti,Michael Szarek,David Szalay,Michael S Conte,Ivan Gudz,Nicole Jaeger,Sebastian Debus,Rick Powell,Lars Norgren,Eva Muehlhofer,Manesh R Patel,Walter Dorigo,Connie N Hess,Henrik Sillesen,Sonia S Anand,Scott D Berkowitz,Warren H Capell,Lloyd Haskell ,Dainis Krieviņš ,Joseph L Mills ,Frans L Moll ,Max V Wohlauer ,Mark R Nehler ,Rupert Bauersachs

doi:10.1016/j.ejvs.2023.03.028

Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits: Presented at the Seventy-fourth Annual Meeting of the Society for Vascular Surgery, San Diego, CA, August 18-21, 2021.

Nicholas Govsyeyev, Marc P Bonaca + Show 25 more

Open Access

https://doi.org/10.1016/j.ejvs.2023.03.028

Copy DOI

Journal: European Journal of Vascular and Endovascular Surgery	Publication Date: Apr 1, 2023
Citations: 1	License type: publisher-specific-oa

#Lower Extremity Bypass Surgery #Symptomatic Peripheral Artery Disease + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits: Presented at the Seventy-fourth Annual Meeting of the Society for Vascular Surgery, San Diego, CA, August 18-21, 2021.

Full Text